Insights from 2023 ASCO® Annual Meeting
L

ASCO® 2023 Insights: "Phase III, Double-Blinded, Randomized, Active-Controlled Study on the Efficacy & Safety of QL1706 + Chemo as 1L Therapy for PD-L1- Advanced or Metastatic NSCLC"

By Insights from 2023 ASCO® Annual Meeting FEATURING Li Zhang
By Insights from 2023 ASCO® Annual Meeting FEATURING Li Zhang
103 views
June 15, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Related Videos

08:49

The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

2.7K views
26:38

Metastatic EGFRm NSCLC: 1L Therapy Options

University of Colorado Cancer Center

T. Patil

408 views
21:50

Multidisciplinary Panel Discussion: New Treatment Options for Surgic…

David Carbone

B. Stiles

297 views
17:20

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Total Health

J. Porter

1.3K views
36:14

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

843 views
17:05

Mediastinal Staging of Lung Cancer

MI&T Congressi

R. Trisolini

485 views
09:52

WCLC 2024 Insights: Interstitial Lung Disease and Lung Cancer - How …

Insights from 2024 WCLC

S. Ikeda

339 views
19:15

ESMO 2024 Summary: EGFRm NSCLC Panel Discussion - MARIPOSA, PAPILLON…

ecancer

I. Gil-Bazo, M. Brandão, B. Besse, E. Felip

260 views
35:40

Year in Review: Lung Cancer

Balazs Halmos

2.6K views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views
03:55

Treatment Updates in Advanced and Metastatic NSCLC - Advances in Tho…

Total Health

J. Porter

169 views
20:04

UChicago Medicine Best of ASCO® 2024: NSCLC

UChicago Medicine Annual Practice Updates in Hematology and Oncology

R. Thawani

274 views
19:33

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

ecancer

E. Felip, A. Spira, A. Passaro, A. Addeo

551 views
15:09

World Lung Cancer Day: Key Insights and Advances in Lung Cancer Trea…

Oncology Data Advisor

S. Kareff, B. Sandy, M. Vojnic

147 views
28:32

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

423 views
09:37

Controversies in NSCLC: Neoadjuvant vs. Adjuvant IO in Early Stage D…

Luis Raez

499 views
14:22

Management of mNSCLC Without Actionable Mutations

Integrity CE

M. Baumgart, S. Liu

123 views
11:45

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in …

2024 ASCO® Annual Meeting Insights Hub

T. Mok

454 views
10:00

WCLC 2024 Summary: Comparing Treatment for Locally Advanced NSCLC - …

Insights from 2024 WCLC

J. Donington

153 views
07:50

WCLC 2024 Insights: FLAURA2 Trial - Impact of Tumor Burden on Outcom…

Insights from 2024 WCLC

N. Valdivieso

157 views
AUTOPLAY